COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s58, 2021. DOI: 10.25251/skin.5.supp.58. Disponível em: https://skin.dermsquared.com/skin/article/view/1409. Acesso em: 19 may. 2025.